Feng Zhang (張鋒), a 2016 Tang Prize winner, explained his latest genome editing tool, called CRISPR/Cas13, in a meeting Wednesday with Tang Prize Foundation CEO Chern Jenn-chuan (陳振川) and a Nobel Prize laureate in Physiology or Medicine at the Massachusetts Institute of Technology (MIT).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
DPP lawmaker Huang Jie included in TIME's 2024 emerging leaders list
10/03/2024 05:44 PM - Science & Tech
Workshop on climate change's ocean impacts concludes in Kaohsiung
10/03/2024 04:59 PM - Politics
U.S. rep sends condolences to Taiwan amid typhoon at National Day reception
10/03/2024 03:44 PM - Society
Taiwan headline news
10/03/2024 02:50 PM - Society
Fire at Pingtung hospital leaves 8 dead, 2 missing
10/03/2024 01:40 PM